(±) 20-HDHA

• Description :

  (±) 20-HDHA ((±) 20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA) . (±) 20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate[1][2][3].

• CAS Number :

  [90906-41-5]

• Product Name Alternative :

  (±) 20-HDoHE

• UNSPSC :

  12352211

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Endogenous Metabolite

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/racemic-20-hdha.html

• Concentration :

  290.28 μM * 750 μL in Ethanol

• Purity :

  97.0

• Solubility :

  10 mM in DMSO

• Smiles :

  CCC(O)/C=C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O

• Molecular Formula :

  C22H32O3

• Molecular Weight :

  344.49

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]VanRollins M, et al. Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate. J Lipid Res. 1984 May;25 (5) :507-17.|[2]Kim HY, et al. Stereochemical analysis of hydroxylated docosahexaenoates produced by human platelets and rat brain homogenate. Prostaglandins. 1990 Nov;40 (5) :473-90.|[3]Hong S, et al. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom. 2007 Jan;18 (1) :128-44.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  Solution, -20°C, 2 years

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported